Question 1

What are the potential risks and side effects of the AAVB-039 treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of AAVB-039 in Participants With Stargardt Disease (STGD1) clinical trial (NCT07161544). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available for Stargardt disease?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of AAVB-039 in Participants With Stargardt Disease (STGD1) clinical trial (NCT07161544). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the process of the subretinal injection involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of AAVB-039 in Participants With Stargardt Disease (STGD1) clinical trial (NCT07161544). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of AAVB-039 in Participants With Stargardt Disease (STGD1) clinical trial (NCT07161544). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of AAVB-039 in Participants With Stargardt Disease (STGD1) clinical trial (NCT07161544). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my participation in this trial affect my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of AAVB-039 in Participants With Stargardt Disease (STGD1) clinical trial (NCT07161544). Contact the study team or your healthcare provider for specific answers.

What this study is about